Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HICON

SODIUM IODIDE I-131

Standard Dose
1-1000mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview HICON is listed in Drugs@FDA under application 021305 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength SOLUTION;ORAL - 1-1000mCi/ML Sponsor JUBILANT Submission history Latest submission status date: 2021-06-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview HICON is listed in Drugs@FDA under application 021305 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength SOLUTION;ORAL - 1-1000mCi/ML Sponsor JUBILANT Submission history Latest submission status date: 2021-06-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.